Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.63B P/E - EPS this Y -12.50% Ern Qtrly Grth -
Income -201.4M Forward P/E -10.32 EPS next Y 52.80% 50D Avg Chg -
Sales 520k PEG -2.38 EPS past 5Y - 200D Avg Chg 18.00%
Dividend N/A Price/Book 4.99 EPS next 5Y 5.00% 52W High Chg -17.00%
Recommedations 1.70 Quick Ratio 3.61 Shares Outstanding 593.13M 52W Low Chg 64.00%
Insider Own 0.09% ROA -28.94% Shares Float 515.43M Beta 0.48
Inst Own 74.17% ROE -60.04% Shares Shorted/Prior 44.66M/54.12M Price 3.20
Gross Margin - Profit Margin - Avg. Volume 5,610,301 Target Price 7.29
Oper. Margin -18,465.13% Earnings Date May 2 Volume 2,355,788 Change -0.31%
About Geron Corporation

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

Geron Corporation News
07/26/24 Geron Announces Updated NCCN Guidelines® Recommending RYTELO™ (imetelstat) for the Treatment of Symptomatic Anemia in Patients with Lower-Risk MDS
07/24/24 Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board
07/23/24 Geron Corporation Announces Chief Commercial Officer to Depart at End of August 2024
07/23/24 Geron (GERN) to Report Q2 Earnings: What's in the Cards?
07/18/24 Geron to Announce Second Quarter 2024 Financial Results on August 8, 2024
07/11/24 3 Under-$10 Biotech Stocks That Could Make You Rich
07/08/24 3 Longevity Stocks to Buy for Anti-Aging Breakthroughs
06/20/24 Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/13/24 Geron Corporation's (NASDAQ:GERN) large institutional owners must be happy as stock continues to impress, up 27% over the past week
06/13/24 How to Invest in Penny Stocks in 2024: 3 Best Picks
06/11/24 3 Penny Stocks to Buy if You Want to Spend Less and Earn More
06/10/24 Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
06/08/24 Is Geron Stock a Buy Following Its First New Drug Approval?
06/07/24 Geron stock pops on FDA approval for blood cancer drug
06/07/24 Why Is Exact Sciences (EXAS) Down 17.5% Since Last Earnings Report?
06/07/24 FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
06/07/24 Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
06/07/24 Midday movers: GameStop, DocuSign fall; Lyft, Geron rise
06/07/24 FDA approves Geron’s RYTELO for MDS associated anaemia
06/06/24 Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia
GERN Chatroom

User Image JonathanGillbee Posted - 8 minutes ago

$gern Analyst price target for next week.;,. join-stock-trading-us-insights.social-marketar.xyz

User Image tjguy Posted - 4 hours ago

@TimingTimingTiming There are ALWAYS flippers and it's hard to know when they win the battle and when the stock overcomes the selling. $Gern was approved in June and did not fall so it's hard to predict, but sure, there will be flippers.

User Image Akwaba76 Posted - 10 hours ago

$GERN Will the IMpactMF study fase 3 be finished in 2026? Could you imagine what this would do for the company, if they suceed? Maybe if there is a buyout too soon, we will miss that potential gain....

User Image BottomzUp Posted - 12 hours ago

$SGMO $GERN Mcap 2.8 BILLION

User Image DoctrBenway Posted - 12 hours ago

$SGMO $GERN Well, it's been a great week. Everyone get plenty of rest for the real fireworks, next week!

User Image HailDaHall Posted - 13 hours ago

$GERN News out Geron Announces Updated NCCN Guidelines Recommending RYTELO(TM) (imetelstat) for the Treatment of Symptomatic Anemia in Patients with Lower-Risk MDS https://marketwirenews.com/news-releases/geron-announces-updated-nccn-guidelines-xae-recommen-6354150759882468.html $GERN

User Image Mail_Dog Posted - 13 hours ago

$GERN Hopefully SHs will be clapping in glee after ER report on 8 Aug. Never know if JS & Co. have some more positive developments to share with investors..!

User Image aj_ Posted - 13 hours ago

$GERN wait until that other bit of news comes out…

User Image xMonti Posted - 13 hours ago

$GERN ✌️

User Image finna_buy_more Posted - 14 hours ago

$GERN gorgeous

User Image Crivit Posted - 14 hours ago

$GERN BP are watching closely!

User Image Kimasztu Posted - 14 hours ago

$GERN Hold your shares don't sell it to shorts! before 8th of August we will be at 6$🥳😎💪

User Image Rickster4retirement Posted - 15 hours ago

$GERN Somebody just working this up and down between $4.20 and 4.90. This was the second time through.

User Image BioRich Posted - 15 hours ago

$BBIO $TRVI $GERN $ARDX and $ARVN looking good today and we expect them to hold into next week. $TRVI is a sleeper here so keep an eye on them. Like and follow for more tips/suggestions. We'd love to hear yours too. Let's make some money. Cheers!

User Image Kimasztu Posted - 15 hours ago

$GERN Panic mode😂

User Image share97 Posted - 15 hours ago

$GERN just a stupid thing to sell honestly

User Image patso1964 Posted - 16 hours ago

$GERN @KingCryptoMan it is for sure 10% but nothing stop the doctors to use Rytelo instead of Lustapercept for 1st line this is a huge + for us

User Image patso1964 Posted - 17 hours ago

$GERN common baby you can do better than this let it fly

User Image MarcusEpi Posted - 17 hours ago

$GERN Bout to tumble back down. Pretty obvious

User Image Kimasztu Posted - 17 hours ago

$GERN soon the are going to wake up like this....😂

User Image Kimasztu Posted - 17 hours ago

$GERN shorts are leaving in a fear right now😂

User Image MuckMuck Posted - 17 hours ago

$GERN Time for some Upgrades to fuel the fire!

User Image patso1964 Posted - 17 hours ago

$GERN

User Image Mail_Dog Posted - 17 hours ago

$GERN Hey 45M Shorties…I say it’s prime-time to board the GERN Gravy Train whilst you still can..! The Gravy Train could be leaving very soon for the land of riches imo..!!

User Image MarcusEpi Posted - 17 hours ago

$GERN Can’t hold gains

User Image Kimasztu Posted - 17 hours ago

$GERN PT 25-35$ for BO easy!

User Image jacksparo Posted - 17 hours ago

$GERN I said it I am adding the dip and so what if the CFO left the company ? The company already secured FDA approved and they are doing good .

User Image Kimasztu Posted - 17 hours ago

$GERN The most funny is that the best is yet to come;-P Few days ago I said she is going to run!

User Image Micky11 Posted - 17 hours ago

$GERN when the COO left was a good buying opportunity don't know about now.

User Image nevermind889 Posted - 17 hours ago

$GERN great recovery!!

Analyst Ratings
Needham Buy Jul 26, 24
Barclays Overweight Jun 11, 24
Barclays Overweight Jun 10, 24
Stifel Buy Jun 10, 24
Needham Buy Jun 7, 24
Wedbush Outperform Jun 7, 24
Needham Buy May 2, 24
Baird Neutral Apr 30, 24
TD Cowen Buy Apr 29, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
O'Farrell Elizabeth G. Director Director Aug 24 Buy 2.28 13,186 30,064 26,220 08/24/23
LAWLIS V BRYAN Director Director May 11 Sell 3 35,000 105,000 05/11/23
LAWLIS V BRYAN Director Director May 11 Option 1.1 35,000 38,500 35,000 05/11/23
Molineaux Susan Director Director May 01 Sell 2.48 35,000 86,800 05/01/23
Molineaux Susan Director Director May 01 Option 1.1 35,000 38,500 35,000 05/01/23
GRETHLEIN ANDREW J EVP, Chief Operating.. EVP, Chief Operating Officer Feb 09 Sell 3.03 384,719 1,165,699 02/10/23
GRETHLEIN ANDREW J EVP, Chief Operating.. EVP, Chief Operating Officer Feb 09 Option 1.51 150,000 226,500 384,719 02/10/23
Bloom Olivia Kyusuk EVP, Chief Financial.. EVP, Chief Financial Officer Feb 08 Sell 3.08 400,000 1,232,000 74,588 02/10/23
Bloom Olivia Kyusuk EVP, Chief Financial.. EVP, Chief Financial Officer Feb 08 Option 1.51 400,000 604,000 474,588 02/10/23
SCARLETT JOHN A Chairman, President.. Chairman, President and CEO Feb 08 Sell 3.04 1,340,000 4,073,600 02/10/23
SCARLETT JOHN A Chairman, President.. Chairman, President and CEO Feb 08 Option 1.5 1,340,000 2,010,000 446,668 02/10/23
EASTHAM KARIN Director Director Jan 13 Option 1.10 35,000 38,500 109,047 01/17/23
GRETHLEIN ANDREW J EVP, Chief Operating.. EVP, Chief Operating Officer Sep 12 Option 1.7 234,719 399,022 234,719 09/14/22
EASTHAM KARIN Director Director Apr 20 Option 1.41 35,000 49,350 74,047 04/21/22